Erratum
- PMID: 30726682
- PMCID: PMC6827962
- DOI: 10.1200/JCO.18.02406
Erratum
Erratum for
-
CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer.J Clin Oncol. 2018 Oct 1;36(28):2836-2844. doi: 10.1200/JCO.2017.76.6212. Epub 2018 Aug 15. J Clin Oncol. 2018. PMID: 30110194 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources